The latest price target for American Healthcares (NYSE:AHR) was reported by RBC Capital on November 18, 2024. The analyst firm set a price target for $30.00 expecting AHR to rise to within 12 months (a possible 8.11% upside). 24 analyst firms have reported ratings in the last year.

The latest analyst rating for American Healthcares (NYSE:AHR) was provided by RBC Capital, and American Healthcares maintained their outperform rating.

There is no last upgrade for American Healthcares

There is no last downgrade for American Healthcares.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of American Healthcares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for American Healthcares was filed on November 18, 2024 so you should expect the next rating to be made available sometime around November 18, 2025.

While ratings are subjective and will change, the latest American Healthcares (AHR) rating was a maintained with a price target of $28.00 to $30.00. The current price American Healthcares (AHR) is trading at is $27.75, which is out of the analyst’s predicted range.